City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.
September 25, 2017 | City of Hope
City of Hope doctors and scientists have published a study in OncoImmunology about a triple-negative breast cancer patient whose disease regressed rapidly when she took part in an experimental treatment that combines a p53 cancer vaccine, which was developed at City of Hope, and a drug that blocks a specific cancer-aiding protein.
February 7, 2017 | Jyoti Madhusoodanan
Next-generation sequencing (NGS) tests can quickly pinpoint tumor mutations that can be targeted with specific drugs, offering a route to precision therapies for many cancer types. Coupled with new drugs that target tumor-specific genomic changes, NGS tests carry the potential to transform modern cancer care.
February 3, 2017 | Denise Heady
Defeating cancer cannot be done alone. It requires a team approach. Here are just a few examples of how City of Hope scientists and physicians are working together to create leading-edge approaches to end cancer.
December 8, 2016 | Samantha Bonar
City of Hope patient Susan Young - diagnosed with late-stage triple negative breast cancer - has had a remarkable response to a revolutionary new treatment, a combination of the p53 cancer vaccine and a drug that blocks a specific cancer-aiding protein.
July 23, 2015 | Amanda Traxler
Becoming what’s known as an independent scientific researcher is no small task, especially when working to translate research into meaningful health outcomes. Yet that independent status is vital, enabling researchers to lead studies and avenues of inquiry that they believe to be promising.
March 19, 2013 | Hiu Chung So
Just as diabetics have to check their blood sugar levels and HIV patients people have to monitor their viral loads, cancer patients and their doctors have to rely on regular, accurate testing to determine whether their therapies are working.